glp 1 drugs fda approved for weight loss New GLP-1 Pill Foundayo (Orforglipron) Gets Approval Obesity What's New in Obesity Treatment?

Use a new sterile needle each time and keep a sharps bin for disposal of used needles

A section reserved for HealthVerity Marketplace data illustrates the richness of real-world evidence available to inform strategic decisions

To view or add a comment, sign in A lot of GOOD news today in biotech + pharma: Breast cancer win in Ph3 trial for AstraZeneca + Daiichi Sankyo US (survival benefit vs chemotherapy) TCGX (TCG Crossover) raises $1.3B third fund focused on biotech + life sciences Trogenix's "Trojan Horse"-tech for cancer biotech lands 70M Series A AstraZeneca + Algen Biotechnologies sign up to $555M AI-powered drug discovery partnership Chiesi Group + Arbor Biotechnologies up to $2.1B rare disease partnership Eli Lilly and Company to invest up to $1B in Indian-based CDMO partnerships For all the news, check out the full (free) TLDR Biotech newsletter here ---------------------------------------- One skimmable email per day to keep up with biotech and pharma Big thanks to Promoveo Health for supporting this newsletter - they've built 100+ pharma sales teams for companies of all sizes, and they can do it for your org as well

Some plans may cover these medications, while others may have restrictions or exclusions

In 2017, the FDA initially approved Semaglutide, marketed as Ozempic , from the pharmaceutical behemoth Novo Nordisk, to assist individuals with type 2 diabetes in managing their blood sugar levels

The SURMOUNT-1 trial formally assessed weight loss of tirzepatide against placebo in obesity